Altre lingue Amicus Therapeutics, Inc.

Azioni

FOLD

US03152W1099

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:02 23/04/2024			Variaz. 5gg	Var. 1 gen.
10,7 ^USD	-1,11%		+1,33%	-24,59%

18/03	AMICUS THERAPEUTICS, INC. : JPMorgan Chase ottimista sul caso	ZM
05/03	Un insider di Amicus Therapeutics ha venduto azioni per un valore di 389.543 dollari, secondo un recente deposito SEC	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Amicus Therapeutics : ESG Report	20/03
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report	20/03
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing	05/03
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	04/03
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	01/03
Amicus Therapeutics Swings to Q4 Earnings, Revenue Rises	28/02
Earnings Flash (FOLD) AMICUS THERAPEUTICS Posts Q4 EPS $0.01, vs. Street Est of $-0.04	28/02
Amicus Therapeutics, Inc. Provides Earnings Guidance for the Year 2024	28/02
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates	28/02
Amicus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Amicus Therapeutics : Fourth Quarter and Full Year 2023 Results Conference Call and Webcast	28/02
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024	15/02
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti + Opfolda at the 20th Annual WORLDSymposium	09/02
Amicus Therapeutics Insider Sold Shares Worth $390,018, According to a Recent SEC Filing	08/02
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™	08/02
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024	01/02
Amicus Therapeutics Insider Sold Shares Worth $683,958, According to a Recent SEC Filing	24/01
Amicus Therapeutics Insider Sold Shares Worth $404,106, According to a Recent SEC Filing	18/01
Amicus Therapeutics Insider Sold Shares Worth $934,659, According to a Recent SEC Filing	12/01
Amicus Therapeutics Insider Sold Shares Worth $449,545, According to a Recent SEC Filing	10/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Amicus Therapeutics, Inc.

Azioni

FOLD

US03152W1099

Altre lingue

Filtri